{"cik":"0001827401","ticker":"DRUG","name":"BRIGHT MINDS BIOSCIENCES INC.","sic_code":"2834","sic_description":"Pharmaceutical Preparations","exchange":"Nasdaq","state_of_incorporation":"A1","fiscal_year_end":"0930","first_filing_date":"2026-05-12","last_filing_date":"2026-07-02","url":"/sec/cik-0001827401","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0001062993-26-003506","form_type":"SCHEDULE 13D/A","form_type_family":"other","doc_date":"2026-07-02","title":"SCHEDULE 13D/A — BRIGHT MINDS BIOSCIENCES INC. — 2026-07-02","url_slug":"/sec/cik-0001827401/schedule-13d-a/0001062993-26-003506","edgar_url":"https://www.sec.gov/Archives/edgar/data/1827401/0001062993-26-003506-index.html"},{"accession_number":"0001062993-26-003005","form_type":"6-K","form_type_family":"current","doc_date":"2026-06-03","title":"6-K — BRIGHT MINDS BIOSCIENCES INC. — 2026-06-03","url_slug":"/sec/cik-0001827401/6-k/0001062993-26-003005","edgar_url":"https://www.sec.gov/Archives/edgar/data/1827401/0001062993-26-003005-index.html"},{"accession_number":"0001062993-26-002975","form_type":"6-K","form_type_family":"current","doc_date":"2026-06-02","title":"6-K — BRIGHT MINDS BIOSCIENCES INC. — 2026-06-02","url_slug":"/sec/cik-0001827401/6-k/0001062993-26-002975","edgar_url":"https://www.sec.gov/Archives/edgar/data/1827401/0001062993-26-002975-index.html"},{"accession_number":"0001062993-26-002801","form_type":"6-K","form_type_family":"current","doc_date":"2026-05-20","title":"6-K — BRIGHT MINDS BIOSCIENCES INC. — 2026-05-20","url_slug":"/sec/cik-0001827401/6-k/0001062993-26-002801","edgar_url":"https://www.sec.gov/Archives/edgar/data/1827401/0001062993-26-002801-index.html"},{"accession_number":"0000902664-26-002546","form_type":"SCHEDULE 13G","form_type_family":"other","doc_date":"2026-05-15","title":"SCHEDULE 13G — BRIGHT MINDS BIOSCIENCES INC. — 2026-05-15","url_slug":"/sec/cik-0001827401/schedule-13g/0000902664-26-002546","edgar_url":"https://www.sec.gov/Archives/edgar/data/1827401/0000902664-26-002546-index.html"},{"accession_number":"0001213900-26-055371","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-12","title":"SCHEDULE 13G/A — BRIGHT MINDS BIOSCIENCES INC. — 2026-05-12","url_slug":"/sec/cik-0001827401/schedule-13g-a/0001213900-26-055371","edgar_url":"https://www.sec.gov/Archives/edgar/data/1827401/0001213900-26-055371-index.html"}],"related_endpoints":{"profile":"/sec/DRUG/profile","timeline":"/sec/DRUG/timeline","peers":"/sec/DRUG/peers","insider_pulse":"/sec/DRUG/insider-pulse","insider_summary":"/sec/DRUG/insider-summary","insider_transactions":"/sec/DRUG/insider-transactions","form144":"/sec/DRUG/form144","holdings_as_filer":"/sec/DRUG/holdings","financial_facts":"/sec/DRUG/financial-facts","derivatives":"/sec/DRUG/derivatives","officers":"/sec/DRUG/officers","insider_network":"/sec/DRUG/insider-network","risk_flags":"/sec/DRUG/risk-flags","filings":"/sec/DRUG/filings","cross_topic_dossier":"/api/v1/dossier?ticker=DRUG"}}